Sample sizes for trials involving multiple correlated must-win comparisons

Pharmaceutical Statistics

Volumn 11, Issue 2, 2012, Pages 177-185

  Julious, Steven A ^a   McIntyre, Nikki E ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

co primary endpoints; multiplicity; power; sample size; Type II error

Indexed keywords

ARTICLE; BIVARIATE ANALYSIS; CALCULATION; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ERROR; METHODOLOGY; NORMAL DISTRIBUTION; SAMPLE SIZE; STUDY DESIGN;

CONTROLLED CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; HUMANS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 84858437513     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.515     Document Type: Article

References (15)

1. Berger RL, Hsu JC,. Bioequivalence trials, intersection-union tests and equivalence confidence sets. Statistical Science 1996; 11: 283-319. (Pubitemid 126706143)
2. Chen JJ, Wang S-J,. Testing for treatment effects on subsets of endpoints. Biometrical Journal 2002; 44 (5): 1-17.
3. Dallow HS, Leonov SL, Roger JH,. Practical usage of O'Brien's OLS and GLS statistics in clinical trials. Pharmaceutical Statistics 2008; 7 (1): 53-68. (Pubitemid 351385326)
4. Senn S, Bretz F,. Power and sample size when multiple endpoints are considered. Pharmaceutical Statistics 2007; 6 (3): 161-170. (Pubitemid 47455256)
5. Yeo A, Qu Y,. Evaluation of the statistical power for multiple tests: a case study. Pharmaceutical Statistics 2009; 8 (1): 5-11.
6. ICH E9. Statistical principles for clinical trials, (1998;). Available at: (last accessed 6 April 2011).
7. Julious SA,. Tutorial in Biostatistics: Sample sizes for clinical trials with Normal data. Statistics in Medicine 2004; 23: 1921-1986. (Pubitemid 38787092)
8. Julious SA,. Sample sizes for clinical trials. Chapman and Hall: London, England, 2009;.
9. Sidak Z,. Rectangular confidence regions for the means of multivariate normal distributions. JASA 1967; 62: 626-633.
10. Eaton ML, Muirhead RJ,. On a multiple endpoints testing problem. Journal of Statistical Planning and Inference 2007; 137: 3416-3429.
11. Xiong C, Yu K, Gao F, Yan Y, Zhang Z,. Power and sample size for clinical trials when efficacy is required in multiple endpoints: application to an Alzheimer's treatment trial. Clinical Trial 2005; 2: 387-393. (Pubitemid 41586023)
12. Genz A, Bretz F,. 2009;. Computation of multivariate normal and t probabilities. In Lecture Notes in Statistics, Vol. 195. Springer: London, England.
13. Sankoh AJ, Huque AJ, Dubey SD,. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Statistics in Medicine 1997; 16: 2529-2542. (Pubitemid 27490059)
14. Genz A, Bretz F, Miwa T, Mi X, Leisch F, Scheipl F, et al,. Multivariate Normal and t Distributions, (2010;). Available at: (last accessed 6 April 2011).
15. Bretz F, Hothorn T, Westfall P,. Multiple comparisons using R. CRC Press: Boca Raton, 2010.